Categories:

• Agriculture and Forestry
• Automotive
• Biotechnology and Pharmaceuticals
• Chemicals
• Construction and Maintenance
• Consumer Goods and Services
• Electronics and Electrical
• Energy and Environment
• Food and Related Products
• Industrial Goods and Services
• Information Technology
• Materials
• Real Estate
• Telecommunications
• Textiles and Nonwovens
• Transportation and Logistics

Popular Tags:

• player
• mp4
• mp4 player
• screen
• player screen
• screen mp4
• 4gb
• player 4gb
• 4gb mp4
• card
• slot
• player card
• 18inch
• inch
• 15inch
• inch mp4
• inch player
• flash
• style
• builtin

Home › a Biogen blames lower-than-expected Tecfidera sales partly on safety concerns

 

a Biogen blames lower-than-expected Tecfidera sales partly on safety concerns

2015-04-24 22:54:30| Biotech - Topix.net

Biogen's Tecfidera was the biggest locally-developed drug to be approved in the U.S. in 2013. It's expected to make more than $4 billion in revenue in 2018.

Tags: sales safety concerns partly

Category:Biotechnology and Pharmaceuticals

Latest from this category	All news
»	05.07 Tropical Storm Beryl Graphics 05.07 Atlantic Tropical Weather Outlook 05.07 Tropical Storm Beryl Public Advisory Number 28A 05.07 Summary for Tropical Storm Beryl (AT2/AL022024) 05.07 Still no sign of herd rebuilding 05.07 Eastern North Pacific Tropical Weather Outlook 05.07 Tubi and Pluto lead U.S. surge in free streaming 05.07 Tubi free streaming service launches in the UK More »